Yongli Li

903 total citations
32 papers, 530 citations indexed

About

Yongli Li is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yongli Li has authored 32 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yongli Li's work include Autophagy in Disease and Therapy (6 papers), Ferroptosis and cancer prognosis (5 papers) and MicroRNA in disease regulation (4 papers). Yongli Li is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Ferroptosis and cancer prognosis (5 papers) and MicroRNA in disease regulation (4 papers). Yongli Li collaborates with scholars based in China, United States and Canada. Yongli Li's co-authors include Changzheng Li, Yun Fu, Cuiping Li, Yanjie Sun, Tengfei Huang, Michael E. Williams, Ronald P. Taylor, Andrew W. Pawluczkowycz, Margaret A. Lindorfer and Jinying Li and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Yongli Li

29 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongli Li China 14 228 153 137 131 67 32 530
Shi Feng China 16 242 1.1× 91 0.6× 112 0.8× 76 0.6× 68 1.0× 63 770
Yuanjun Jiang China 18 365 1.6× 111 0.7× 175 1.3× 66 0.5× 115 1.7× 47 734
Hao Feng China 15 405 1.8× 190 1.2× 252 1.8× 60 0.5× 65 1.0× 35 668
Yi Su China 11 390 1.7× 149 1.0× 163 1.2× 49 0.4× 69 1.0× 30 728
Ling Huang China 13 229 1.0× 211 1.4× 134 1.0× 61 0.5× 57 0.9× 49 740
Shibo Lin China 12 242 1.1× 93 0.6× 115 0.8× 126 1.0× 50 0.7× 38 667
Guandou Yuan China 17 343 1.5× 48 0.3× 213 1.6× 163 1.2× 88 1.3× 55 698
Suk‐young Lee South Korea 16 395 1.7× 111 0.7× 148 1.1× 48 0.4× 60 0.9× 43 719
Xiangguang Shi China 15 204 0.9× 113 0.7× 90 0.7× 48 0.4× 66 1.0× 32 510

Countries citing papers authored by Yongli Li

Since Specialization
Citations

This map shows the geographic impact of Yongli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongli Li more than expected).

Fields of papers citing papers by Yongli Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongli Li. The network helps show where Yongli Li may publish in the future.

Co-authorship network of co-authors of Yongli Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongli Li. A scholar is included among the top collaborators of Yongli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongli Li. Yongli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Yun, Qiufeng Zhao, Yongli Li, et al.. (2025). NCOA4-mediated ferroptosis conducive to EMT inhibition in colorectal cancer cells was achieved through the PI3K/AKT/mTOR pathway. Scientific Reports. 15(1). 39542–39542.
2.
Zhao, Shuai, Yongli Li, Qiang Guo, et al.. (2024). Recovery of Li from waste Li-containing Al electrolytes with high F and Na contents by using a CaO roasting–water leaching process. Journal of Environmental Management. 368. 122222–122222. 7 indexed citations
3.
Guo, Qiang, et al.. (2024). Non-clay bricks with high compressive strength made from secondary aluminum dross and waste glass. Journal of Material Cycles and Waste Management. 26(3). 1517–1526. 1 indexed citations
4.
Wang, Rufang, et al.. (2023). Ferritinophagy-mediated apoptosis and paraptosis induction involved MAPK and PI3K/AKT pathway in mechanism of an iron chelator. Biochemical Pharmacology. 218. 115874–115874. 7 indexed citations
6.
Li, Yongli, et al.. (2021). The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway. Journal of Inorganic Biochemistry. 218. 111413–111413. 35 indexed citations
7.
Li, Longlong, Hao Li, Yongli Li, et al.. (2021). Ferritinophagy‐Mediated ROS Production Contributed to Proliferation Inhibition, Apoptosis, and Ferroptosis Induction in Action of Mechanism of 2‐Pyridylhydrazone Dithiocarbamate Acetate. Oxidative Medicine and Cellular Longevity. 2021(1). 5594059–5594059. 12 indexed citations
10.
Li, Yongli, et al.. (2020). The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway. Chemico-Biological Interactions. 328. 109196–109196. 34 indexed citations
11.
Sun, Yanjie, et al.. (2019). Ferritinophagic Flux Activation in CT26 Cells Contributed to EMT Inhibition Induced by a Novel Iron Chelator, DpdtpA. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 15 indexed citations
12.
Li, Yongli, Tengfei Huang, Yun Fu, et al.. (2019). Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway. PLoS ONE. 14(9). e0215886–e0215886. 17 indexed citations
13.
Huang, Tengfei, Yanjie Sun, Yongli Li, et al.. (2018). Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy‐Mediated Lysosomal ROS Generation. Oxidative Medicine and Cellular Longevity. 2018(1). 4928703–4928703. 30 indexed citations
14.
15.
Liu, Huiqin, Yue Huang, Yongli Li, et al.. (2017). Susceptibility vessel sign predicts poor clinical outcome for acute stroke patients untreated by thrombolysis. Experimental and Therapeutic Medicine. 14(5). 5207–5213. 4 indexed citations
16.
Li, Yongli, et al.. (2016). Research on the application of the zero discharge of the wastewater from pharmacy production. 36(12). 111. 1 indexed citations
17.
Rong, Yihui, Haihan Song, Bing Zhu, et al.. (2012). Association of Toll-like Receptor 3 Polymorphisms with Chronic Hepatitis B and Hepatitis B-Related Acute-on-Chronic Liver Failure. Inflammation. 36(2). 413–418. 30 indexed citations
18.
Li, Yongli, Michael E. Williams, John B. Cousar, et al.. (2007). Rituximab-CD20 Complexes Are Shaved from Z138 Mantle Cell Lymphoma Cells in Intravenous and Subcutaneous SCID Mouse Models. The Journal of Immunology. 179(6). 4263–4271. 50 indexed citations
20.
Gao, Runlin, et al.. (1996). A novel polymeric local heparin delivery stent: Initial experimental study. Journal of the American College of Cardiology. 27(2). 85–86. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026